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http://dx.doi.org/10.1016/j.jds.2013.1Abstract Background/purpose: To examine the effects of fibroblast growth factor-2 (FGF-2)/
calcium silicate (CS) cement on material characters and in vitro primary human dental pulp
cell (hDPC) behavior.
Materials and methods: Setting time and diametral tensile strength (DTS) of CS and CS/FGF-2
composite were measured. PrestoBlue assay was used for evaluating primary hDPC prolifera-
tion. Alkaline phosphatase and osteocalcin expression in HDPCs cultured on the specimens
were determined by enzyme-linked immunosorbent assay. One-way analysis of variance was
used to evaluate the significance of the differences between the mean values.
Results: Setting time and DTS of CS were not significantly different (P > 0.05) between CS hy-
dration with H2O or FGF-2. Cell proliferation and osteogenic properties increased significantly
(P < 0.05) with FGF-2 mixed CS. The CS/FGF-2 composite enhanced hDPC proliferation and
osteogenic differentiation as compared to pure CS cement.
Conclusion: CS combined with FGF-2 is biocompatible with hDPCs. It not only promotes hDPC
proliferation but also helps in differentiating reparative hard tissue. Thus, we suggest that the
CS/FGF-2 composite has the potential for hard tissue defect repair.
Copyright ª 2014, Association for Dental Sciences of the Republic of China. Published by Else-
vier Taiwan LLC. All rights reserved.ntistry, Chung Shan Medical University, Taichung City, Taiwan.
(T.-H. Huang).
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146 B.-C. Wu et alIntroductionMineral trioxide aggregate (MTA) is a biocompatible mate-
rial and developed by Torabinejad’s team in 1993, which
has several clinical applications in endodontic treatment,
such as root-end fillings, pulp capping, pulpotomy, perfo-
ration repairs, and apexification treatment.1e3 It is
a complex mixture of 20% bismuth oxide for radiopacity and
similar to Portland cement, which consists of tricalcium
silicate (Ca3SiO5), dicalcium silicate (Ca2SiO4), tricalcium
aluminate (Ca3Al2O6), tetracalcium aluminoferrite, and
5% gypsum.4 In previous studies, we found that the newly
developed calcium silicate cement (CS) showed an advan-
tageously shortened setting time,5 excellent bioactivity,
and good biocompatibility.6 Moreover, we recently showed
that CS not only stimulates the proliferation and differen-
tiation of human dental pulp cells (hDPCs) in vitro,7e9 but
also reduced inflammation in vivo.10
Several growth factors have been verified as potential
therapeutic agents for hard-tissue formation.11,12 Fibro-
blast growth factors (FGFs) play an important role in the
control of cell adhesion, proliferation, and differentiation
in several tissues including bone.13,14 Notably, FGF-2 has
been found to enhance cell proliferation and osteogenic
differentiation in bone marrow mesenchymal cells.15,16
FGF-2 signaling played an important role of in the control
of osteoprogenitor cells, and knockout of FGF-2 gene in
mice results in decreased bone marrow stromal cell oste-
ogenic differentiation and changed bone formation.17 FGF
binding to FGF receptor (FGFR) leads to receptor phos-
phorylation of intrinsic tyrosine residues, including
mitogen-activated protein kinase and phosphatidylinositol
3-kinase.18,19 In hard tissue, phosphorylation of
extracellular-related kinase, mitogen-activated protein ki-
nases, and protein kinase C have been proved to enhance
osteogenic gene expression.20,21
In a clinical case, tricalcium phosphate ceramic combined
with growth factor and placed in a bone defect after peri-
apical surgery was shown to enhance bone regeneration.22 It
can help regeneration of vital tissue with necrotic pulp and
periapical lesions.22Growth factors/cytokines arekey factors
in tissuewoundhealingandthis combination reduced immune
function and promoted proliferation and differentiation of
cells participating in wound healing.23 FGF-2 is expressed
during tooth development, associated with tooth morpho-
genesis, and promotes the differentiation of dental pulp cells
into odontoblasts in culture.24 A search of the literature re-
veals an absence of any publication discussing the cellular
effects of the growth factor combinedwith CS. The aimof the
present studywas to evaluateCS/FGF-2 composite properties
and pulp cell biological effects. It is hypothesized that CS
combined with FGF-2 can promote the osteogenesis protein
markers expression and help in mineralization.
Materials and methods
Preparation of CS specimens
The CS cement was made according to our previously re-
ported laboratory procedures.5,25 Appropriate amounts of
65% CaO (Showa, Tokyo, Japan), 25% SiO2 (High PureChemicals, Saitama, Japan), and 5% Al2O3 (Sigma-Aldrich,
St Louis, MO, USA) powders were mixed by a conditioning
mixer (ARE-250; Thinky, Tokyo, Japan). After sintering at
1400C, the granules were ball milled in EtOH using a
centrifugal ball mill (Retsch S 100; Retsch, Hann, Germany)
and then dried in an oven. CS cement was mixed according
to the liquid/powder ratio of 0.33 mL/g. FGF-2 (ProSpec,
Rehovot, Israel) was dissolved in double distilled (dd)H2O,
and the concentration was 3 mg/mL. After mixing, the
cement fully covered of the 24-well plate (GeneDireX, Las
Vegas, NV, USA) to a thickness of 2 mm The samples were
stored in an incubator at 100% relative humidity and 37 C
for 1 day. Prior to the cell experiments, all specimens were
sterilized by immersion in 75% ethanol followed by expo-
sure to UV light for 1 hour.
Setting time and strength
After mixing, the cement was placed into a Teflon cylin-
drical mold (diameterZ 6 mm) under a pressure of 0.7 MPa
for 1 minute and tested using a 400 g Gillmore needle with a
1 mm diameter, according to International organization for
standardization 9917-1 (ISO 9917-1). Six specimens were
tested for each measurement.
As for mechanical performance testing, the cement was
molded into a cylindrical mold to a diameter of 6 mm and
thickness of 2 mm and the specimens were stored in an
incubator at 100% relative humidity and 37C for 24 hours to
set. The testing was conducted on an EZ-Test machine
(Shimadzu, Kyoto, Japan) at a loading rate of 0.5 mm/
minute to obtain diametral tensile strength (DTS).
In vitro release of FGF-2
As for FGF-2 release testing, the cement (0.1 g) was molded
into a cylindrical mold to a diameter of 6 mm and thickness
of 3 mm and the specimens were stored in an incubator at
100% relative humidity and 37C for 24 hours to set. The
release of FGF-2 was measured by soaking the specimens in
1 mL of Dulbecco’s modified Eagle medium (DMEM; Caisson
Laboratories, North Logan, UT, USA) at 37C for several
time points. The amount of FGF-2 in DMEM was measured
using the FGF-2 enzyme-linked immunosorbent assay kit
(ELISA; Invitrogen, Grand Island, NY, USA), and the FGF-2
content following the manufacturer’s instructions. All ex-
periments were carried out in triplicate.
Human dental pulp cell isolation and culture
Human dental pulp cells (hDPCs) were derived freshly from
a caries free, intact premolar that was extracted for the
purpose of orthodontic treatment. The patient provided
informed consent, and approval for the study was obtained
from the committee of the Chung Shan Medicine University
Hospital (CSMUH No. CS11187). The tooth was split sagit-
tally with a chisel and pulp tissue was immersed in phos-
phate buffered saline (PBS) contained type I collagenase.
The tissue was cut into fragments and placed in plates
containing DMEM, supplemented with 10% fetal bovine
serum (Caisson Laboratories) for 3 days. Cell culture media
were supplemented with 100 units/mL penicillin-G, 100 mg/
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was successively passed at a ratio of 1e3 until used for
testing (Passage 4e8).
FGF-2 effect of cell proliferation
The proliferation of hDPCs cultured in the presence of FGF-
2 was evaluated by PrestoBlue assay (Invitrogen). Briefly,
5  103 cells/mL hDPCs were seeded in a 24-well overnight
with normal DMEM. Then, hDPCs were treated with DMEM
containing FGF-2 at concentrations of 12.5 ng/mL, 25 ng/
mL, and 50 ng/mL for different times (1, 3, 7 days). At the
end of the culture period, the medium was discarded and
washed with PBS three times. Each well was filled with a
1:9 solution of PrestoBlue in fresh DMEM and incubated at
37C for 60 minutes. The solution in each well was trans-
ferred to a new 96-well plate. Plates were read using a
multiwell spectrophotometer (Hitachi, Tokyo, Japan) at
570 nm with a reference wavelength of 600 nm. The results
were obtained in triplicate from three separate experi-
ments for each test.
Cell proliferation
Cell suspensions at a density of 104 cells/mL were directly
seeded over each specimen. Cell cultures were incubated
at 37C in a 5% CO2 atmosphere. After different culturing
times, cell proliferation was evaluated using the PrestoBlue
assay. Cells cultured on the tissue culture plate without the
cement were used as a control (Ctl). The samples of CS or
Ctl mixed with FGF-2 were named CSF or CtlF (DMEM con-
taining 25 ng/mL FGF-2), respectively.
Alkaline phosphatase activity assay
Secretion of alkaline phosphatase (ALP) activity, it was
determined at 3 days, 7 days, and 14 days after cell seed-
ing. Briefly, the cells were lysed using 0.2% NP-40, and
centrifuged at 3600g for 15 minutes. ALP activity was
determined by p-nitrophenyl phosphate (pNPP; Sigma-
Aldrich) as the substrate. Each sample was mixed with
pNPP in 1 M diethanolamine buffer for 15 minutes. The
reaction was stopped by the addition of 5 N NaOH and
quantified by absorbance at 405 nm. All experiments were
done in triplicate.
ELISA analysis for osteocalcin protein
Osteocalcin (OC) protein released from pulp cells cultured
on different substrates for 7 days and 15 days after cell
seeding. The OC ELISA kit (Invitrogen) was used to deter-
mine OC content following the manufacturer’s instruction.
OC concentration was measured by correlation with a
standard curve. Blank disks were treated as controls. All
experiments were done in triplicate.
Small interfering RNA transfection
Small interfering RNA (siRNA) for FGFR was purchased from
GeneDireX. In the experiments, hDPCs were harvested andseeded on a 24-well plate at a concentration of 2  105
cells per well, and transiently transfected with FGFR-
specific siRNAs (FGFR-specific siRNA sense: 50-CGGAGAU
GAUGAGGAUGACACCGAU-30 and antisense: 30-AUCGGUGU
CAUCCUCAUCAUCUCCG-50) or mock siRNA (sense: 50-UUCU
CCGAACGUGUCACGUTT-30 and antisense: 30-ACGUGACA
CGUUCGGAGAATT-50) using Lipofectamine 2000 (Invitrogen)
according to the manufacturer’s instructions for 48 hours.
Cellular levels of the proteins specifically silenced were
assessed using a western blot, immunofluorescence stain-
ing, and cytotoxicity.
After transfection, cell pellets were lysis in a NP-40 lysis
buffer (Invitrogen) at 4C for 30 minutes, and the lysates
were centrifuged at 15,000g. Total protein concentration
was measured using the Bio-Rad DC Protein Assay kit. Thirty
mg of protein extracts were separated using sodium dodecyl
sulfateepolyacrylamide gel electrophoresis and were
blotted onto polyvinylidene difluoride membranes. After
blocking in 5% bovine serum albumin (Sigma-Aldrich) for 1
hour, the membrane was immunoblotted with the primary
anti-FGFR and b-actin (GeneTex, San Antonio, TX, USA) for
2 hours, then washed three times in a Tris-buffer saline
containing 0.05% Tween-20 (Sigma-Aldrich). A horseradish
peroxidase-conjugated secondary antibody was subse-
quently added, and the proteins were visualized with
enhancement using enhanced chemiluminescent detection
kits (Invitrogen). The stained bands were scanned and
quantified using a densitometer (Syngene bioimaging sys-
tem; Syngene, Frederick, MD, USA) and ImageJ (National
Institutes of Health, Bethesda, MD, USA). Protein expres-
sion levels were normalized to the b-actin band for each
sample. The results were obtained in triplicate from three
separate samples for each test.
Immunofluorescence staining
After transfection for 2 days, hDPCs were washed with cold
PBS, and the adherent cells were fixed in 4% para-
formaldehyde (Sigma-Aldrich) for 30 minutes at room
temperature and permeabilized with 0.1% Triton X-100
(Sigma-Aldrich) in PBS (PBS-T). The cells were blocked with
PBS supplemented with 5% bovine serum albumin prior to
incubation with primary antibodies against anti-FGFR for 2
hours. To reveal the FGFR, hDPCs were washed with PBS-T,
followed by incubation with goat anti-rabbit IgG antibodies
conjugated to Alexa Fluor 488 (Invitrogen). Finally, the
nuclei and F-actin cytoskeleton were stained with 300 nM
40,6-diamidino-2-phenylindole (DAPI; Invitrogen) and phal-
loidin conjugated to Alexa Fluor 546 (Invitrogen) in PBS for
60 minutes, respectively. After washing three times with
PBS-T, the cells were viewed under indirect immunofluo-
rescence using a Zeiss Axioskop2 microscope (Carl Zeiss,
Thornwood, NY, USA).
FGFR knockdown inhibitors on proliferation and OC
level
After transfection, cells were cultured on different sub-
strates for 1, 3, and 7 days. The cell proliferation and OC
protein secretion were analyzed by PrestoBlue assay and
ELISA, respectively.
Figure 1 (A) The setting time and (B) diametral tensile
strength (DTS) of calcium silicate were hydrated with water
and fibroblast growth factor-2 (FGF-2). Statistical data are
presented as means  standard deviation for n Z 6.
Figure 2 Release percent profile of fibroblast growth factor-
2 from calcium silicate in Dulbecco’s modified Eagle medium.
Statistical data are presented as means  standard deviation
for n Z 6.
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A one-way variance statistical analysis was used to evaluate
the significance of the differences between the groups in
each experiment. A Scheffe’s multiple comparison test was
used to determine the significance of the deviations in the
data for each specimen. In all cases, the results were
considered statistically significant with P < 0.05.
Results
Setting time and DTS
The setting time is one of most clinically relevant factors.
CS set within 15.3  1.0 minutes, and 15.6  1.3 minutes
when mixed with ddH2O and FGF-2, respectively (P > 0.05;Fig. 1A). Fig. 1B shows the DTS values of cement specimens.
One-way analysis of variance of the DTS data shows that the
variations in strength between specimens are not signifi-
cant (P > 0.05). CS had a strength value of 3.2  0.2 MPa
and 3.3  0.1 MPa when mixed with ddH2O and FGF-2,
respectively.
In vitro release of FGF-2
The amount of FGF-2 loaded in CS was about 100 ng. The
in vitro release profiles of FGF-2 from CS are plotted in
Fig. 2. The initial burst release was observed in the first 12
hours, with 20.67 ng FGF released from CS. Approximately
27.33 ng FGF-2 was released over 3 days.
hDPC proliferation
The proliferation of hDPCs cultured in DMEM with FGF-2
concentrations of 0e50 ng/mL is shown in Fig. 3. There was
no significance between 0 ng/mL and 12.5 ng/mL (P > 0.05)
at all times. As the concentrations of FGF-2 were increased
to 25 ng/mL, hDPCs were significantly increased at Day 1
(P < 0.05). In addition, we evaluated the cell proliferation
on CS without and with FGF-2 (Fig. 4). Cell viability steadily
increased in Ctl on Days 1e7, indicating increasing numbers
of viable cells. The optical density values of the two FGF-2-
containing groups were significantly higher (P < 0.05) than
those obtained without FGF-2 after 1 day. Moreover, the
CSF showed highest hDPCs growth (P < 0.05) at all groups
for all culture time period.
Osteogenesis
ALPexpression of hDPCs cultured on different substrates was
examined. As shown in Fig. 5, analysis of quantitative ex-
amination data shows that the ALP activity of cells cultured
on the composites increased over time throughout the assay
Figure 5 Alkaline phosphatase (ALP) activity of human
dental pulp cells cultured on specimens mixed without and
with fibroblast growth factor-2 (F) for different time-points.
Statistical data are presented as means  standard deviation
for n Z 6. * Indicates a significant difference (P < 0.05)
compared to specimens without fibroblast growth factor-2
(Ctl). CS Z calcium silicate.
Figure 3 Proliferation of human dental pulp cells treated
with culture media containing various fibroblast growth factor-
2 concentrations for different times. Statistical data are pre-
sented as means  standard deviation for n Z 6. * Indicates a
significant difference (P < 0.05) compared to 0 ng/mL.
Effects of CS/FGF-2 on osteogenesis in hDPCs 149periodwith ahigher value in the substrates containing FGF-2.
The ALP activity of the hDPCs seeded on CSF was higher than
that of the cells onother groupswith a statistically significant
difference (P < 0.05) throughout the culture period.
OC released from hDPCs was measured 7 days and 14
days after seeding (Fig. 6). OC secretion on all groups
increased significantly from Day 7 to Day 14. At Day 7, there
was a significant increase of OC in FGF-2-containing groups.
Interestingly, the OC secretion by cells cultured on CtlF and
CS was similar (P > 0.05), and significantly lower (P < 0.05)
than that secreted by cells on CSF.
FGFR knockdown
Western blots showed effective FGFR knockdown by pairs of
FGFR-specific siRNA in the cells compared to Ctl and theFigure 4 Proliferation of human dental pulp cells cultured on
specimens without and with fibroblast growth factor-2 (F) at
various time points. Statistical data are presented as
means  standard deviation for nZ 6. * Indicates a significant
difference (P < 0.05) compared to specimens without fibro-
blast growth factor-2. ** Indicates a significant difference
(P < 0.05) compared to control (Ctl). CS Z calcium silicate.control with mock siRNA transfection, respectively
(Fig. 7A). Transfection with FGFR siRNA optimally reduced
FGFR protein levels by 56% in hDPCs after 48 hours. To
further investigate the effects of siRNA on hDPCs functions,
FGFR was analyzed using immunofluorescence microscopy
(Fig. 7B). The assembly of the F-actin cytoskeleton was
subsequently examined with rhodamine-labeled (red). It
can be clearly seen that cells expressed lower levels of
FGFR (green) after siRNA transfection. There was no cyto-
toxicity of hDPCs after the FGFR knockdown procedures
(Fig. 7C).Figure 6 Osteocalcin (OC) amount of human dental pulp
cells cultured on specimens mixed without and with fibroblast
growth factor-2 (F) for different time-points. Statistical data
are presented as means  standard deviation for n Z 6. * In-
dicates a significant difference (P < 0.05) compared to speci-
mens without fibroblast growth factor-2 (Ctl). CS Z calcium
silicate.
Figure 7 (A) Western blotting of fibroblast growth factor receptor (FGFR) knockdown by pairs of FGFR-specific small interfering
RNAs (siRNAs) in human dental pulp cells. * Indicates a significant difference (P < 0.05) compared to control (Ctl). (B) Immuno-
fluorescence images of nuclei (blue), F-actin (red), and FGFR (green) in human dental pulp cells treated with FGFR-specific siRNAs
for 48 hours.
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level
As shown in Fig. 8, the proliferation (Fig. 8A) and OC
(Fig. 8B) levels were analyzed after treatment of FGFR
siRNA on hDPCs. For all time-points, FGFR knockdown by
the use of FGFR siRNA decreased hDPCs proliferation and
OC secretion on CS/FGF-2 composite, and there was no
significance (P > 0.05) between samples with and without
FGF-2.Discussion
MTA has a wide range of applications, including pulp
capping, perforation repair, apexification procedures, and
root-end filling.26,27 In a previous study we confirmed that
MTA and CS were calcium-silicate based materials with
similar physicalechemical and biological properties.28,29
Additionally, the viability of pulp cells cultured on CS
cement was greater than those cultured on MTA for all
culture times, suggesting that CS cement could be used in
Figure 8 The effects of fibroblast growth factor receptor-
specific small interfering RNAs transfection on (A) prolifera-
tion and (B) osteocalcin (OC) secretion in human dental pulp
cells cultured on specimens without and with fibroblast growth
factor-2. Values not sharing a common letter are significantly
different at P < 0.05.
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occurring proteins that cause cellular adhesion, prolifera-
tion, and differentiation. Several reporters directed at
clinical use have progressed, including use of enamel ma-
trix derivative (EMD),30 platelet-derived growth factor-
BB,31 bone morphogenic protein (BMP)-2,32,33 BMP-7,34 and
transforming growth factor.35 The growth factors (BMP-7,
epithelial growth factor, transforming growth factor, and
insulin-like growth factor -1) have been used to alter the
sensitivity of hDPCs in commonly used restoration mate-
rials.36 Previous studies have shown that FGF-2 promotes
alveolar bone formation and cementum regeneration in
dogs.37 Moreover, FGF-2 is known to be involved in all
stages of osteogenesis, including osteoblast cell prolifera-
tion, differentiation, maturation, and apoptosis. By
contrast, the problem with this kind of administration is
that a large amount of FGF-2 protein was used because of
its fast release in vivo.38 To overcome this disadvantage, in
attempting to treat more severe bone defects with FGF-2,
the concept of a substitute needs to be introduced. Many
studies have developed composites for the delivery of FGF-
2 based on sulfated or natural materials,37e39 showinghopeful results. Therefore, we have carried out CS mixed
with FGF-2 and for local delivery in order to evaluate the
capacity of these systems for inducing cell proliferation and
differentiation.
Setting time is the most important factor in clinical use;
a long setting duration could affect the cement’s inability
to maintain dimensional stability and support stresses when
placed into a hard bone defect.40 As for CS containing FGF-
2, the setting time and DTS were similar to pure CS
(P > 0.05). The rate of FGF-2 release from CS was in
accordance with an earlier report of the release charac-
teristics of porosity.41 We conjecture that the primary
mechanism of FGF-2 release from the CS surface is prior to
12 hours. The efficacious concentrations of FGF-2 for
different biological function have been determined in
several previous studies. Previous studies verify that FGF-2
at a concentration of >10 ng/mL may have adverse effects
on bone formation. Recently, Sogo et al39 found that FGF-2
immobilized at 2.72 ng/cm2 on the hydroxyapatite surface
has that ability to promote new bone formation. The pre-
sent study showed that CS combined with growth factors on
cultured hDPCs could promote proliferation at a long time
period of culture. We presume that the amount of FGF-2
released from CS was high enough to enhance hDPCs
behavior. Our findings are similar to the above result that
FGF-2 combined with CS showed synergistic effects on
culture hDPC proliferation than CS alone. The increasing
culture time and concentrations appeared better for hDPC
growth.44,45
ALP is an important biochemical marker of bone and
dentin formation which is secreted by osteoblasts.42 ALP
expression was dominantly increased in the growth factor-
included group at all time points. ALP is considered to play
a key role in the mineralization of reparative dentin.43 The
high ALP expression in hDPCs culture in the CS/FGF-2 group
can promote in reparative dentin formation. OC is a non-
collagenous protein found in bone and dentin. It is secreted
by osteoblasts and thought to play a role in mineralization
and calcium ion homeostasis. In the present study, the
expression of the OC marker was higher in the CS/FGF-2
groups. There is a synergistic effect to hDPCs cultured
with growth factor combined CS groups. However, FGFR
knockdown inhibited the proliferation and differentiation
of hDPCs on CS/FGF-2, indicating that the blockade of FGF-
2 signal transduction affects cell behavior.
In conclusion, the CS combined with growth factors was
biocompatible with hDPCs. It not only promotes hDPCs to
proliferation but also helps in differentiating reparative
dentin. We suggest that this CS/FGF-2 composite has the
potential for used in reparative dentin.Conflicts of interest
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